Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. - Wikidata - awgldk - TriplyDB

Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

http://www.wikidata.org/entity/Q37004996

about

Hepatic stem cells: A viable approach for the treatment of liver cirrhosis Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix Unlocking the vital role of host cells in hair follicle reconstruction by semi-permeable capsules.Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels.Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering.Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.Liver bioengineering: current status and future perspectives Cellularized biosynthetic microhydrogel polymers for intravascular liver tissue regeneration therapy Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes Regression and persistence: remodelling in a tissue engineered axial vascular assembly.Ethical issues in cellular and molecular medicine and tissue engineering.Use an alginate scaffold-bone marrow stromal cell (BMSC) complex for the treatment of acute liver failure in rats.Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds In utero hepatocellular transplantation in rats.Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro.Changes of anabolic processes at the cellular and molecular level in chronic wounds under topical negative pressure can be revealed by transcriptome analysis A PET-compatible tissue bioreactor for research, discovery, and validation of imaging biomarkers and radiopharmaceuticals: system design and proof-of-concept studies.Cell patterning for liver tissue engineering via dielectrophoretic mechanisms.Liver Cell Culture Devices.Cellular Transplantation for Liver Diseases.T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix.Future of bioartificial liver support.Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors.Hair organ regeneration via the bioengineered hair follicular unit transplantation.Three-dimensional culture in a microgravity bioreactor improves the engraftment efficiency of hepatic tissue constructs in mice.External inosculation as a feature of revascularization occurs after free transplantation of murine liver grafts.Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix liver scaffolds.A new generation of sodium chloride porogen for tissue engineering.Liver cell therapy: is this the end of the beginning?Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

P2860

Q26864363-3394630D-ABBF-47F5-BC75-D19E2BCCB274 Q28081183-40CA645E-359C-4C34-B509-C95797F82623 Q33797379-102939EA-F858-49FA-B761-D69BBD85C3C2 Q33824557-CA0C2763-0357-4369-ABEE-D06C9E3DFB1D Q33937916-1D744400-FEA9-4A3B-A4AA-3CFA9A6012BF Q34226581-1C2367AB-3F57-4CEB-A557-FB14B3FEF549 Q34322889-367F7ADF-B3A6-4527-A0AE-4096D7662EBA Q34500596-572EADCE-B873-4CEB-A2FD-3CB108244748 Q35065329-656006DA-41E8-4CFE-9D8A-84562E2B3A3F Q35832024-FD2037F5-CB5D-4392-960A-B9C96AADD6D5 Q35862429-3ACD7110-F83F-43AE-937E-52E50A87378D Q36182755-61813A48-5940-4791-B695-5378F832C901 Q37123945-B9DA7F13-5702-40CF-927B-1DF7175FF1C5 Q37154871-C2AD8E33-E09A-4F1D-B61F-B440DE4984B7 Q37193186-5FDE577A-55B7-46E7-9069-C792D31CD246 Q37295477-89F014B2-47E8-4625-ADC3-2D980F37D88E Q37677560-18F8719F-BF88-424C-AAEF-DDE19CE39BB8 Q38225910-9829670D-5AC6-4E92-A78A-FDB3540304E0 Q38960582-7E252D5B-1151-4EE9-91D8-FAE48AB5874F Q39043994-D973C508-4DCD-43DA-9932-370F356710AB Q39221799-1FF6BE3B-1DBF-4C78-A166-D69535C1F934 Q39805179-C69269D7-E1CA-45E5-B997-3490FDBA463F Q41132397-205E87AE-8F23-4F7B-9ECA-6D2709AB0BC6 Q42178015-B5C6A94D-27D0-4F25-B740-922FC1494380 Q42204739-B6A7C784-F4DB-48C4-8999-BB91EC7D1F5D Q44738565-9332B52F-EB9F-4A75-92C8-C7E9B37CF21F Q46863800-40434CE6-7203-422E-BBCA-4FE54239E865 Q48222610-E8F3A8E0-AA57-49C3-803D-E941F42BB0A6 Q48515790-29E53076-70EE-4DB9-83DD-612276AD3A80 Q52714594-CA3F0D16-2E1A-4052-A9D7-52F61270FCB7 Q53155879-1C5E5A04-1FBC-4EEF-97A4-CC569066D3A9

P2860

Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

http://www.wikidata.org/entity/Q37004996

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@en

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@nl

type

label

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@en

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@nl

prefLabel

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@en

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@nl

P1433

Q37004996-78955C85-BD01-4DB1-978B-44D86B061B6B

P1476

Q37004996-873DF021-E430-48C1-BCBA-155A2AF41B9F

P2093

Q37004996-00A98E68-24B1-42BD-83A0-8A000E508CB7

Q37004996-010EA7C1-2817-48DF-A3DC-31987A4A5ABF

Q37004996-1DECC536-7E0B-48B3-B740-179685A1508B

Q37004996-66AF6E44-8100-4318-93FE-8658620A30F8

Q37004996-9DCDF962-D4D1-4488-B1BA-1CA2CA00FA56

Q37004996-9DF414EA-32C0-4038-BAF3-3D0409E14F7E

Q37004996-9ED61E05-6FE7-4519-8C8F-3A27356A1E6D

P2860

Q37004996-00E5E80A-B4DA-45DA-BDBC-6FB4F5F3F911

Q37004996-03B7A63D-A488-4C28-9F5A-40E56BE9F135

Q37004996-05AD10D4-1C00-4B07-B28B-B564758142B3

Q37004996-06DC7D7F-0993-453B-A3AA-08491DC0BA0B

Q37004996-085F8D90-D795-498D-BCD3-B581DC263F81

Q37004996-183C6F33-4C4E-4771-8927-18E3BE7B4D4B

Q37004996-185915F8-95AE-45BD-8D8A-DDCAAF0E03EF

Q37004996-20238EA8-0323-48A4-83D8-D9A34A00CAE5

Q37004996-29005674-5835-4AA4-BD73-019ABA955CAB

Q37004996-2B05CF5C-84B4-414E-B435-7E4E0399A696

P304

Q37004996-15ADE2BD-7440-487B-8FC9-464AFEAD7D90

P31

Q37004996-9AEFA147-39D2-4CB6-95ED-224869B5EEF2

Q37004996-AB479337-DC68-45BC-A187-22ED74CFF8A0

P356

Q37004996-BF4D1836-E979-4A42-BD92-5FC96AACC69F

P433

Q37004996-03AF6C59-43BF-4353-8D9B-8620FCDC669D

P478

Q37004996-BAE2A28A-BC90-46B5-8D1F-696C145A06D6

P577

Q37004996-13524818-E56E-4ACD-9D32-81E8BAD83177

P5875

Q37004996-DF2DA981-F249-4B64-8528-101C7CD6BF4A

P698

Q37004996-8A13E1AA-5A25-4C47-93F7-4E4AF3787725

P921

Q37004996-42D6012F-CB07-4A43-828D-80267EEE5392

Q37004996-8F9C10CC-585C-4BCE-861A-33B4C9CC99FA

Q37004996-A9AB40FA-4C6A-47DB-96B9-B5A52C57B24D

Q37004996-D6DA55F6-60FD-40B4-9690-FAEC26E00659

Q37004996-E0D17646-A0DB-4989-A186-5A4041C36FE4

P932

Q37004996-096946ED-44EF-48C0-956D-489E62EABA30

P356

J.1582-4934.2007.00162.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Hepatic tissue engineering: fr ...... therapies from the laboratory.

@en

P2093

Dietrich Kluth

http://www.w3.org/2001/XMLSchema#string

Helge Bruns

http://www.w3.org/2001/XMLSchema#string

Henning C Fiegel

http://www.w3.org/2001/XMLSchema#string

Joseph P Vacanti

http://www.w3.org/2001/XMLSchema#string

Peter M Kaufmann

http://www.w3.org/2001/XMLSchema#string

Raymund E Horch

http://www.w3.org/2001/XMLSchema#string

Ulrich Kneser

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation

The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro

Tissue engineering

Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells.

Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells.

A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support.

Phase I clinical trial with the AMC-bioartificial liver.

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood

Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

P304

56-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2007.00162.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5826372

http://www.w3.org/2001/XMLSchema#string

P698

18021311

http://www.w3.org/2001/XMLSchema#string

P921

tissue engineering

biomedical investigative technique

P932

3823472

http://www.w3.org/2001/XMLSchema#string